Evidence map›Paper›PMID 35250117›Full record

ArticleComputers & chemical engineering2022

Discerning in vitro pharmacodynamics from OD measurements: A model-based approach.

Iordanis Kesisoglou, Vincent H Tam, Andrew P Tomaras, Michael Nikolaou

Open access · greenAbstract read
In one paragraph

Article in Computers & chemical engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Rapid Design of Combination Antimicrobial Therapy againstComputers & chemical engineering · 2025
    Article
  7. Article
  8. Ecotoxicity ofToxics · 2023
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Iordanis KesisoglouChemical & Biomolecular Engineering Department, University of Houston, 4226 MLK Blvd, Houston TX 77004, United States.
Vincent H TamDepartment of Pharmacy Practice and Translational Research, University of Houston, 4349 MLK Blvd, Houston TX 77204, United States.
Andrew P TomarasBacterioScan Inc. 2210 Welsch Industrial Ct, St. Louis, MO 63146 United States.
Michael NikolaouChemical & Biomolecular Engineering Department, University of Houston, 4226 MLK Blvd, Houston TX 77004, United States.ORCID 0000-0003-0241-6600
University of Houston · US

Funding

Personalized Antimicrobial Combinations to Combat ResistanceR01AI140287 · NIAID · UNIVERSITY OF HOUSTON · PI VINCENT H TAM · 2018 to 2026
$5.9M
NIAID NIH HHS R01 AI140287
6 · The paper itself

Abstract

Time-kill experiments can discern the pharmacodynamics of infectious bacteria exposed to antibiotics in vitro, and thus help guide the design of effective therapies for challenging clinical infections. This task is resource-limited, therefore typically bypassed in favor of empirical shortcuts. The resource limitation could be addressed by continuously assessing the size of a bacterial population under antibiotic exposure using optical density measurements. However, such measurements count both live and dead cells and are therefore unsuitable for declining populations of live cells. To fill this void, we develop here a model-based method that infers the count of live cells in a bacterial population exposed to antibiotics from continuous optical-density measurements of both live and dead cells combined. The method makes no assumptions about the underlying mechanisms that confer resistance and is widely applicable. Use of the method is demonstrated by an experimental study on

Indexed as

Combination therapyMathematical modelingMulti-drug resistant bacteriaPharmacodynamics

Identifiers

PMID35250117
PMCPMC8896896
OpenAlexW4200189489

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.